Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13

Analysis of the Financial Impact of Using Cangrelor on the Safety and Efficacy Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Whom Oral Therapy with P2Y12 Inhibitors is Not Feasible or Desirable, in Spain

Total article views   HTML views PDF downloads Totals
7,695 Dovepress* 7,041+ 680 7,721
PubMed Central* 654 133 787
Totals 7,695 813 8,508
*Since 27 January 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar